Veru participates in a virtual investor kol connect segment

-- moderated discussion with preeminent obesity expert, louis j. aronne, md, facp and mitchell steiner, m.d., f.a.c.s, president, ceo, and founder, of veru -- miami, fl, may 08, 2025 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the release of a virtual investor kol segment featuring louis j. aronne, md, facp.
VERU Ratings Summary
VERU Quant Ranking